DARUNAVIR
- Strength
- 600 mg/1
- Form
- Tablet, Film Coated
- Class
- Protease Inhibitor
Lupin Pharmaceuticals, Inc.
DARUNAVIR ETHANOLATE and COBICISTAT
Listed by A-S Medication Solutions
This is a combination product. It is not interchangeable with a single-ingredient medicine containing only one of these.
| Dosage form | Tablet, Film Coated |
|---|---|
| Route | Oral |
| Drug class | Cytochrome P450 3A Inhibitor; Protease Inhibitor |
| Approval route | NDA — original brand approval |
| NDC code | 50090-1723 |
| FDA application | NDA205395 |
| RxNorm concept | 1600704 |
| Package sizes listed | 1 |
| Marketed since | January 2015 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Lupin Pharmaceuticals, Inc.
Lupin Pharmaceuticals, Inc.
darunavir
Janssen Products LP
darunavir
Janssen Products LP
darunavir
Janssen Products LP
darunavir
Janssen Products LP
darunavir
Janssen Products LP
DARUNAVIR ETHANOLATE and COBICISTAT
Janssen Products, LP
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.